Detalhe da pesquisa
1.
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
Cell
; 184(8): 2201-2211.e7, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743891
2.
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
Cell
; 184(1): 169-183.e17, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296701
3.
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Cell
; 184(12): 3205-3221.e24, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015271
4.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
5.
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
Cell
; 183(4): 996-1012.e19, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010815
6.
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
Cell
; 182(4): 828-842.e16, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645326
7.
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Cell
; 183(4): 1024-1042.e21, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991844
8.
BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
Nat Immunol
; 23(1): 33-39, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848871
9.
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.
Cell
; 173(7): 1783-1795.e14, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29731169
10.
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.
Cell
; 169(4): 597-609.e11, 2017 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475892
11.
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
Cell
; 170(2): 273-283.e12, 2017 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708997
12.
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.
Immunity
; 54(9): 2133-2142.e3, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453880
13.
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Immunity
; 53(5): 925-933.e4, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129373
14.
Intranasal vaccination.
Nat Immunol
; 22(9): 1071, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34429547
15.
Protective neutralizing influenza antibody response in the absence of T follicular helper cells.
Nat Immunol
; 17(12): 1447-1458, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798619
16.
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Nat Immunol
; 17(9): 1102-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339099
17.
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.
Nature
; 602(7898): 676-681, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016198
18.
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Nat Immunol
; 16(2): 170-177, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25501631
19.
Ebola virus antibody decay-stimulation in a high proportion of survivors.
Nature
; 590(7846): 468-472, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33505020
20.
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Nature
; 595(7867): 426-431, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126625